LISDEXAMFETAMINE Spirig HC caps 60 mg bte 30 pce

7680690310059 Pharmacode 1120356 CH-69031 N06BA12 01.10.2.

Active substances:

LISDEXAMFETAMINE Spirig HC caps 60 mg bte 30 pce
Fiches Amavita / Sun Store / Coop Vitality

Details

GTIN
7680690310059
Pharmacode
1120356
Product number
6903105
CPT
-
Packaging group
30
Unit
Kapsel(n)
Composition
lisdexamfetamini dimesilas 60 mg corresp. dexamfetaminum 17.8 mg, cellulosum microcristallinum, magnesii stearas, carmellosum natricum conexum corresp. natrium 0.67 mg, Kapselhülle: gelatina, E 171, E 127, E 133, aqua purificata, Drucktinte: lacca, propylenglycolum, E 171, E 172 (nigrum), pro capsula.

Articles (1)

Lisdexamfetamin Spirig HC 60 mg, Hartkapseln
Kapseln
30
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
12/06/2026
Patient information leaflet
Français
12/06/2026
Patient information leaflet
Italien
12/06/2026
Professional SmPC
Allemand
12/06/2026
Professional SmPC
Français
12/06/2026
Professional SmPC
Italien
12/06/2026

Detailed composition

Substance Quantity Type Category
lisdexamfetamini dimesilas
60.0 MG Substance Wirkstoff (Principe actif)
dexamfetaminum
17.8 MG Substance WIIS
cellulosum microcristallinum
- Substance HNIDK
magnesii stearas
- Substance HNIDK
carmellosum natricum conexum
- Substance HNIDK
natrium
0.67 MG Substance HBESI
gelatina
- Substance HNIDK
E 171
- Substance FNIDK
E 127
- Substance FIMDK
E 133
- Substance FIMDK
aqua purificata
- Substance HNIDK
lacca
- Substance HNIDK
propylenglycolum
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
E 171
- Substance FNIDK
E 172 (nigrum)
- Substance FTODK

Authorization holder

Spirig HealthCare AG

4622 Egerkingen

Authorization information

Swissmedic authorization number
69031
Drug name
Lisdexamfetamin Spirig HC, Hartkapseln
Galenic form
KAHA
ATC Code
N06BA12
Authorization status
Z
Dispensation category
A+
First authorization
28/03/2024
Authorization expiration date
27/03/2029
IT number
01.10.2.
Domain
Human medicine
Field of application
Aufmerksamkeitsdefizit-Hyperaktivitätsstörung (ADHS)

Packaging details

Description (FR)
LISDEXAMFETAMINE Spirig HC caps 60 mg bte 30 pce
Description (DE)
LISDEXAMFETAMIN Spirig HC Kaps 60 mg Ds 30 Stk
Market launch
28/03/2024
Narcotic (BTM)
A

Other packaging sizes

LISDEXAMFETAMINE Spirig HC caps 20 mg bte 30 pce
30 KAP
View
LISDEXAMFETAMINE Spirig HC caps 30 mg bte 30 pce
30 KAP
View
LISDEXAMFETAMINE Spirig HC caps 40 mg bte 30 pce
30 KAP
View
LISDEXAMFETAMINE Spirig HC caps 50 mg bte 30 pce
30 KAP
View
LISDEXAMFETAMINE Spirig HC caps 70 mg bte 30 pce
30 KAP
View
Buy us a coffee Explore the data